Security key
83086J200
Skye Bioscience, Inc. - Common Stock, par value $0.001 (SKYE)
CUSIP: 83086J200
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.001
- Total 13F shares
- 25,729,728
- Total 13F value
- $100,585,169
- Share change
- +1,818,320
- Put/Call ratio
- 69%
- SEC-reported price per share
- $3.91
- Number of holders
- 72
- Value change
- +$1,208,054
- Number of buys
- 35
- Number of sells
- 18
- Shares outstanding
- 37,329,162
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
72
Top holders
10
SKYE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Skye Bioscience, Inc. SEC filings
Skye Bioscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83086J200
Recent filing periods:
Ownership snapshot
Top reported holders of SKYE - Skye Bioscience, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Versant Ventures III, LLC
Disclosed value leader
5AM Venture Management, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $81,537,835
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
5AM Venture Management, LLC has the largest disclosed position value at $81.54M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 5AM Venture Management, LLC's linked filing trail.
Disclosed position value
Top 5
Versant Ventures III, LLC
$9.39M
Emerald Health Sciences Inc.
$3.17M
5AM Venture Management, LLC
$81.54M
Versant Venture Management, LLC
$16.08M
Altium Capital Management LLC
$10.81M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Versant Ventures III, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$9,386,012
501,925,802 shares
|
— | 18 Aug 2023 |
| Emerald Health Sciences Inc. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$3,167,928
169,407,901 shares
|
— | 10 Nov 2022 |
| 5AM Venture Management, LLC |
13F
Company
|
—
denominator unverified
|
$81,537,835
10,179,505 shares
|
— | 30 Jun 2024 |
| Versant Venture Management, LLC |
13F
Company
|
—
denominator unverified
|
$16,081,709
2,007,704 shares
|
— | 30 Jun 2024 |
| Altium Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$10,814,245
1,350,093 shares
|
— | 30 Jun 2024 |
| Logos Global Management LP |
13F
Company
|
—
denominator unverified
|
$10,425,159
1,301,518 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
72
Shares
25,729,728
Rows available
72
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
62
Q3 2024 holders
72
Holder diff
10
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend